Is there a new dawn for selective mineralocorticoid receptor antagonism?
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Nephrology,Internal Medicine
Reference41 articles.
1. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
3. Efficacy of low-dose spironolactone in subjects with resistant hypertension
4. The role of spironolactone in the treatment of patients with refractory hypertension
5. Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An approach to enhance drug solubility: fabrication, characterization, and safety evaluation of Felodipine polymeric nanoparticles;Polymer Bulletin;2024-08-28
2. Comparison of Lidocaine Versus Nifedipine for Attenuation the Cardiovascular Response to Direct Laryngoscopy and Intubation during General Anesthesia;مجلة العلوم والدراسات الإنسانية - كلية الآداب والعلوم – المرج;2024-07-17
3. Anwendung von Organometallkatalysatoren in der API-Synthese;Organometallik in der Prozesschemie;2024
4. Drug and temperature influence on the gel state stability of the phospholipid membranes;The European Physical Journal Special Topics;2023-02-15
5. GRK5 is an essential co-repressor of the cardiac mineralocorticoid receptor and is selectively induced by finerenone;World Journal of Cardiology;2022-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3